| Oct 28 |
PROCEPT BioRobotics Corporation 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 28 |
Procept GAAP EPS of -$0.40 beats by $0.09, revenue of $58.37M beats by $5.18M
|
| Oct 28 |
Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
|
| Oct 28 |
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
|
| Oct 25 |
Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround
|
| Oct 24 |
Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline
|
| Oct 21 |
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 8 |
What Analysts Are Saying About PROCEPT BioRobotics Stock
|
| Oct 7 |
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
|
| Oct 5 |
PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99
|
